# Wells Pharma of Houston LLC – FDA Inspection, Dec 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/c8cff647-1ce7-4e40-92d9-1a3d32332820
Source feed: FDA_Inspections

> FDA inspection 1193883 of Wells Pharma of Houston LLC, December 14, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1193883
- Company Name: Wells Pharma of Houston LLC
- Inspection Date: 2022-12-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1302362 - 2026-04-13](https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/1b69b978-6820-44d2-93c7-77c431525aa3)
- [FDA Inspection 1266232 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/e551c869-05e4-4af7-8e72-26e70172f5b4)
- [FDA Inspection 1144681 - 2021-06-17](https://www.keypedia.com/records/fda_inspections/wells-pharma-of-houston-llc/08c48720-4f39-4c03-97bb-5fc4b9adc1ed)

Company: https://www.keypedia.com/companies/wells-pharma-of-houston-llc/35e803e2-78a7-4b40-b467-4c1ff012447d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c